Ground Swell Capital’s Basel Medical BMGL Stock Holding History

Ground Swell Capital’s Portfolio BMGL Stock Details BMGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,809	Closed	-$16.5K	–	197
2025 Q4	$16.5K	Buy	+2,809	New	+$41.5K	0.03%	64

Other funds holding BMGL

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

T3 Companies New York $76.8M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ground Swell Capital's BMGL Position: Q1 2026 in Review

Ground Swell Capital sold out of Basel Medical (BMGL) in Q1 2026, closing a stake of 2,809 shares — an estimated $16.5K sold.

Ground Swell Capital first reported a position in BMGL in Q4 2025 and held it in 1 quarter. The position peaked at $16.5K in Q4 2025. 4 funds tracked by Wall St. Rank hold BMGL as of Q1 2026.

Ground Swell Capital reported no remaining Basel Medical position as of Q1 2026 after selling out during the quarter.
Ground Swell Capital sold 2,809 Basel Medical shares in Q1 2026, an estimated $16.5K.
Ground Swell Capital first reported a position in Basel Medical in Q4 2025 and held it in 1 quarter.
Ground Swell Capital's Basel Medical position peaked at $16.5K in Q4 2025.
4 funds tracked by Wall St. Rank held Basel Medical as of Q1 2026.

Based on Ground Swell Capital's 13F filing for Q1 2026, filed 21 Apr 2026.